These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7987033)

  • 21. Left ventricular hypertrophy as a risk factor in hypertension.
    Balogun MO; Dunn FG
    Afr J Med Med Sci; 1996 Sep; 25(3):277-83. PubMed ID: 10457806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ischemic sudden death: critical analysis of risk markers. Part VIII].
    Lopera G; Huikuri HV; Makikallio TH; Castellanos A; Myerburg RJ
    Rev Esp Cardiol; 2000 Apr; 53(4):568-78. PubMed ID: 10758034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of antihypertensive therapy on left ventricular hypertrophy and on its pathophysiologic sequelae.
    Messerli FH
    Blood Press Suppl; 1992; 1():35-6; discussion 37. PubMed ID: 1343271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertensive heart disease, ventricular dysrhythmias, and sudden death.
    Messerli FH; Michalewicz L
    Adv Exp Med Biol; 1997; 432():263-72. PubMed ID: 9433533
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathophysiology and clinical aspects of hypertensive hypertrophy.
    Vogt M; Motz WH; Schwartzkopf B; Strauer BE
    Eur Heart J; 1993 Jul; 14 Suppl D():2-7. PubMed ID: 8103741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the QT interval duration in hypertension with antihypertensive treatment.
    Klimas J; Kruzliak P; Rabkin SW
    Hypertens Res; 2015 Jul; 38(7):447-54. PubMed ID: 25787045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wall stress and hypertension.
    James MA; Saadeh AM; Jones JV
    J Cardiovasc Risk; 2000 Jun; 7(3):187-90. PubMed ID: 11006887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertensive heart disease.
    Diamond JA; Phillips RA
    Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction.
    De Ferrari GM; Salvati P; Grossoni M; Ukmar G; Vaga L; Patrono C; Schwartz PJ
    J Am Coll Cardiol; 1993 Jul; 22(1):283-90. PubMed ID: 8509552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension, left ventricular hypertrophy, and sudden death.
    Tin LL; Beevers DG; Lip GY
    Curr Cardiol Rep; 2002 Nov; 4(6):449-57. PubMed ID: 12379162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Arterial hypertension and left ventricular dysfunction: pathophysiology, diagnosis and therapy].
    Kleber FX; Doering W
    Cardiology; 1993; 82 Suppl 2():9-21. PubMed ID: 8519033
    [No Abstract]   [Full Text] [Related]  

  • 32. Ischemia induces aggravation of baseline repolarization abnormalities in left ventricular hypertrophy: a deleterious interaction.
    Rubulis A; Jensen J; Lundahl G; Tapanainen J; Bergfeldt L
    J Appl Physiol (1985); 2006 Jul; 101(1):102-10. PubMed ID: 16565349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study.
    Morin DP; Oikarinen L; Viitasalo M; Toivonen L; Nieminen MS; Kjeldsen SE; Dahlöf B; John M; Devereux RB; Okin PM
    Eur Heart J; 2009 Dec; 30(23):2908-14. PubMed ID: 19687165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular hypertrophy, arterial hypertension and sudden death.
    Messerli FH
    J Hypertens Suppl; 1990 Dec; 8(7):S181-6. PubMed ID: 2151334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence favoring the hypothesis that ventricular arrhythmias have prognostic significance in left ventricular hypertrophy secondary to systemic hypertension.
    Almendral J; Villacastin JP; Arenal A; Tercedor L; Merino JL; Delcan JL
    Am J Cardiol; 1995 Nov; 76(13):60D-63D. PubMed ID: 7495220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension and coronary artery disease.
    Srikanthan VS; Dunn FG
    Med Clin North Am; 1997 Sep; 81(5):1147-63. PubMed ID: 9308603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of chronic antihypertensive treatment on ischemia-induced lethal ventricular tachyarrhythmias and electrophysiological property in hypertrophied rat hearts].
    Yokoshiki H
    Hokkaido Igaku Zasshi; 1993 Nov; 68(6):862-72. PubMed ID: 8112711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of antihypertensive therapy: cardiac and extracardiac considerations.
    Messerli FH; Soria F
    Cardiology; 1992; 81(4-5):316-24. PubMed ID: 1301259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.